Medtronic Earnings, Revenue Miss in Q4 By Investing.com


© Reuters. Medtronic Earnings, Revenue Miss in Q4

Investing.com – Medtronic (NYSE:) reported on Thursday fourth quarter that missed analysts’ forecasts and revenue that fell short of expectations.

Medtronic announced earnings per share of $1.52 on revenue of $8.09B. Analysts polled by Investing.com anticipated EPS of $1.57 on revenue of $8.44B.

Medtronic shares are up 2% from the beginning of the year, still down 22.33% from its 52 week high of $135.89 set on September 9, 2021. They are outperforming the S&P 500 which is down 16.52% from the start of the year.

Medtronic follows other major Healthcare sector earnings this month

Medtronic’s report follows an earnings missed by Novo Nordisk ADR on April 29, who reported EPS of $0.881 on revenue of $5.96B, compared to forecasts EPS of $0.8828 on revenue of $5.96B.

Pfizer had beat expectations on May 3 with first quarter EPS of $1.62 on revenue of $25.66B, compared to forecast for EPS of $1.49 on revenue of $24.1B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar

Be the first to comment

Leave a Reply

Your email address will not be published.


*